In staying true to our mission to supply the highest quality medications for hypothyroidism, we recently completed some necessary infrastructure upgrades, which included moving to a larger facility, implementing new technology, and refining our processes. These upgrades unfortunately played a role in the backorder of Nature-Throid and WP Thyroid, but were not the only factor.
In the last few years, we started experiencing some major hurdles in obtaining a key raw material. These hurdles disrupted our ability to not only keep up with the growing demand for our medications, but to also keep them cost-effective. We ate burgeoning costs for as long as we could and had minimal price increases compared to others, but the path was unsustainable. This information was kept under wraps for the protection of our patients. Quite frankly, we were concerned if we spoke out about these issues, we would be cut off from our supply and left unable to produce any medication at all. We are happy to report, everything needed to ensure fulfillment of all backorders and uninterrupted, ongoing full-scale production is now in place.
Patients who experience difficulty getting their prescription from their usual pharmacy are encouraged to contact other local pharmacies to see what strengths they have in stock, or check with any of the mail-order pharmacies listed on our website: http://bit.ly/RLCFindAPharmacy.
We will continue to share updates directly with our customers, and patients will continue to be notified of new information on our Facebook page. We are in production and prioritizing strengths based on highest demand, starting with Nature-Throid 1 grain, which will be hitting pharmacy shelves by the end of October. Strengths will be released in all counts – 30s, 60s, 90s, 100s, and 1000s.
Regrettably, we are unable to provide timeframes for other strengths just yet, but we can clear up some rumors:
We sincerely apologize for the strain this backorder has caused for our customers and patients and greatly value your continued support. Every effort is being made to get all strengths stocked as quickly as possible while still adhering to our strict quality standards – our medications are not released outside of +/-2% variance between T4 and T3, while the industry allows for a monograph discrepancy of +/-10%.
We greatly appreciate your understanding and continued support as we make every effort to get back on track as quickly as possible.
The RLC Labs Team